{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:12:59Z","timestamp":1767183179146,"version":"3.48.0"},"reference-count":66,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA043252"],"award-info":[{"award-number":["R01 DA043252"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA044582"],"award-info":[{"award-number":["R01 DA044582"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA047089"],"award-info":[{"award-number":["R01 DA047089"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA050542"],"award-info":[{"award-number":["R01 DA050542"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_nipt-2025-0011_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Opioid use during pregnancy is associated with adverse perinatal outcomes, but its effects on placental biology are not well understood. Because the placenta plays a vital role in fetal development and immune regulation, we examined how maternal opioid exposure influences microbial DNA signatures and immune gene expression in the placenta.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_nipt-2025-0011_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Placentas from opioid-exposed and control C57 BL\/6 female mice were analyzed through 16S rRNA gene sequencing, bulk RNA sequencing and pathway enrichment analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_nipt-2025-0011_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Opioid-exposed placentas showed altered microbial DNA profiles, including increased \u03b1-diversity and enrichment of\n                      <jats:italic>Staphylococcus<\/jats:italic>\n                      spp. Transcriptomic analysis revealed 357 differentially expressed genes, emphasizing immune pathways, including dendritic cell-NK cell crosstalk, immunogenic cell death, and cytokine storm signaling. STAT3 signaling and heparan sulfate biosynthesis were downregulated. Pathways related to apoptosis, cytotoxicity, and neonatal death were upregulated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_nipt-2025-0011_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Maternal opioid exposure may disrupt placental microbial and immune environments, potentially leading to structural compromise through immune-mediated cellular apoptosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/nipt-2025-0011","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:28:38Z","timestamp":1765801718000},"page":"353-362","source":"Crossref","is-referenced-by-count":0,"title":["Maternal opioid use is associated with\u00a0altered placental bacterial DNA and\u00a0activation of\u00a0immune-apoptotic pathways"],"prefix":"10.1515","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-0117","authenticated-orcid":false,"given":"Yaa F.","family":"Abu","sequence":"first","affiliation":[{"name":"Department of Surgery , 12235 University of Miami Miller School of Medicine , Miami , FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2638-5386","authenticated-orcid":false,"given":"Junyi","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Surgery , 12235 University of Miami Miller School of Medicine , Miami , FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arumugam","family":"Jayakumar","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences , 12235 University of Miami Miller School of Medicine , Miami , FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussain","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences , 12235 University of Miami Miller School of Medicine , Miami , FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Paidas","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences , 12235 University of Miami Miller School of Medicine , Miami , FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabita","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Surgery , 12235 University of Miami Miller School of Medicine , Miami , FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"2025123112070693475_j_nipt-2025-0011_ref_001","doi-asserted-by":"crossref","unstructured":"Chu, D, Ma, J, Prince, A, Antony, K, Seferovic, M, Aagard, K. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat Med 2017;23:314\u201326. https:\/\/doi.org\/10.1038\/nm.4272.","DOI":"10.1038\/nm.4272"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_002","doi-asserted-by":"crossref","unstructured":"Aagaard, K, Ma, J, Antony, KM, Ganu, R, Petrosino, J, Versalovic, J. The placenta harbors a unique microbiome. Sci Transl Med 2014;6:1\u201311. https:\/\/doi.org\/10.1126\/scitranslmed.3008599.","DOI":"10.1126\/scitranslmed.3008599"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_003","doi-asserted-by":"crossref","unstructured":"Collado, MC, Rautava, S, Aakko, J, Isolauri, E, Salminen, S. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep 2016;6:1\u201313. https:\/\/doi.org\/10.1038\/srep23129.","DOI":"10.1038\/srep23129"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_004","doi-asserted-by":"crossref","unstructured":"Rackaityte, E, Halkias, J, Fukui, EM, Mendoza, VF, Hayzelden, C, Crawford, ED, et al.. Viable bacterial colonization is highly limited in the human intestine in utero. Nat Med 2020;26:599\u2013607. https:\/\/doi.org\/10.1038\/s41591-020-0761-3.","DOI":"10.1038\/s41591-020-0761-3"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_005","doi-asserted-by":"crossref","unstructured":"de Goffau, MC, Lager, S, Sovio, U, Gaccioli, F, Cook, E, Peacock, SJ, et al.. Human placenta has no microbiome but can contain potential pathogens. Nature 2019;572:329\u201334. https:\/\/doi.org\/10.1038\/s41586-019-1451-5.","DOI":"10.1038\/s41586-019-1451-5"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_006","doi-asserted-by":"crossref","unstructured":"Kennedy, KM, Gerlach, MJ, Adam, T, Heimesaat, MM, Rossi, L, Surette, MG, et al.. Fetal meconium does not have a detectable microbiota before birth. Nat Microbiol 2021;6:865\u201373. https:\/\/doi.org\/10.1038\/s41564-021-00904-0.","DOI":"10.1038\/s41564-021-00904-0"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_007","doi-asserted-by":"crossref","unstructured":"Blaser, MJ, Devkota, S, McCoy, KD, Relman, DA, Yassour, M, Young, VB. Lessons learned from the prenatal microbiome controversy. Microbiome 2021;9:1\u20137. https:\/\/doi.org\/10.1186\/s40168-020-00946-2.","DOI":"10.1186\/s40168-020-00946-2"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_008","doi-asserted-by":"crossref","unstructured":"Parris, KM, Amabebe, E, Cohen, MC, Anumba, DO. Placental microbial \u2013 metabolite profiles and inflammatory mechanisms associated with preterm birth. J Clin Pathol 2021;74:10\u20138. https:\/\/doi.org\/10.1136\/jclinpath-2020-206536.","DOI":"10.1136\/jclinpath-2020-206536"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_009","doi-asserted-by":"crossref","unstructured":"Tomlinson, MS, Lu, K, Stewart, JR, Marsit, CJ, O\u2019Shea, TM, Fry, RC. Microorganisms in the placenta: links to early-life inflammation and neurodevelopment in children. Clin Microbiol Rev 2019;32. https:\/\/doi.org\/10.1128\/cmr.00103-18.","DOI":"10.1128\/CMR.00103-18"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_010","doi-asserted-by":"crossref","unstructured":"Ander, SE, Diamond, MS, Coyne, CB. Immune responses at the maternal-fetal interface. Sci Immunol 2019;4. https:\/\/doi.org\/10.1126\/sciimmunol.aat6114.","DOI":"10.1126\/sciimmunol.aat6114"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_011","doi-asserted-by":"crossref","unstructured":"Ding, J, Maxwell, A, Adzibolosu, N, Hu, A, You, Y, Liao, A, et al.. Mechanisms of immune regulation by the placenta: role of type I interferon and interferon\u2010stimulated genes signaling during pregnancy. Immunol Rev 2022;308:9\u201324. https:\/\/doi.org\/10.1111\/imr.13077.","DOI":"10.1111\/imr.13077"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_012","doi-asserted-by":"crossref","unstructured":"Giugliano, S, Gatti, A, Rusin, M, Schorn, T, Pimazzoni, S, Calanni-Pileri, M, et al.. Maternal gut microbiota influences immune activation at the maternal-fetal interface affecting pregnancy outcome. Nat Commun 2025;16:4326. https:\/\/doi.org\/10.1038\/s41467-025-58533-8.","DOI":"10.1038\/s41467-025-58533-8"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_013","doi-asserted-by":"crossref","unstructured":"Manaster, I, Mandelboim, O. The unique properties of uterine NK cells. Am J Reprod Immunol 2010;63:434\u201344. https:\/\/doi.org\/10.1111\/j.1600-0897.2009.00794.x.","DOI":"10.1111\/j.1600-0897.2009.00794.x"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_014","doi-asserted-by":"crossref","unstructured":"Humphries, A, Simcox, K, Howell, B. A review of the literature: how does prenatal opioid exposure impact placental health and fetal brain development. Dev Psychobiol 2022;65. https:\/\/doi.org\/10.1002\/dev.22378.","DOI":"10.1002\/dev.22378"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_015","doi-asserted-by":"crossref","unstructured":"Jantzie, LL, Maxwell, JR, Newville, JC, Yellowhair, TR, Kitase, Y, Madurai, N, et al.. Prenatal opioid exposure: the next neonatal neuroinflammatory disease. Brain Behav Immun 2020;84:45\u201358. https:\/\/doi.org\/10.1016\/j.bbi.2019.11.007.","DOI":"10.1016\/j.bbi.2019.11.007"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_016","doi-asserted-by":"crossref","unstructured":"Mactier, H, Hamilton, R. Prenatal opioid exposure \u2013 increasing evidence of harm. Early Hum Dev 2020;150:105188. https:\/\/doi.org\/10.1016\/j.earlhumdev.2020.105188.","DOI":"10.1016\/j.earlhumdev.2020.105188"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_017","doi-asserted-by":"crossref","unstructured":"Conradt, E, Flannery, T, Aschner, JL, Annett, RD, Croen, LA, Duarte, CS, et al.. Prenatal opioid exposure: neurodevelopmental consequences and future research priorities. Pediatrics 2019;144. https:\/\/doi.org\/10.1542\/peds.2019-0128.","DOI":"10.1542\/peds.2019-0128"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_018","doi-asserted-by":"crossref","unstructured":"Byrnes, EM, Vassoler, FM. Modeling prenatal opioid exposure in animals: current findings and future directions. Front Neuroendocrinol 2018;51:1\u201313. https:\/\/doi.org\/10.1016\/j.yfrne.2017.09.001.","DOI":"10.1016\/j.yfrne.2017.09.001"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_019","doi-asserted-by":"crossref","unstructured":"Yen, E, Davis, JM. The immediate and long-term effects of prenatal opioid exposure. Front Pediatr 2022;10:1\u20138. https:\/\/doi.org\/10.3389\/fped.2022.1039055.","DOI":"10.3389\/fped.2022.1039055"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_020","doi-asserted-by":"crossref","unstructured":"Abu, Y, Roy, S. Prenatal opioid exposure and vulnerability to future substance use disorders in offspring. Exp Neurol 2021;339:113621. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113621.","DOI":"10.1016\/j.expneurol.2021.113621"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_021","doi-asserted-by":"crossref","unstructured":"Yeoh, SL, Eastwood, J, Wright, IM, Morton, R, Melhuish, E, Ward, M, et al.. Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis. JAMA Netw Open 2019;2:1\u201314. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.7025.","DOI":"10.1001\/jamanetworkopen.2019.7025"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_022","doi-asserted-by":"crossref","unstructured":"McQueen, K, Murphy-Oikonen, J. Neonatal abstinence syndrome. N Engl J Med 2016;375:2468\u201379. https:\/\/doi.org\/10.1056\/nejmra1600879.","DOI":"10.1056\/NEJMra1600879"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_023","doi-asserted-by":"crossref","unstructured":"Hirai, AH, Ko, JY, Owens, PL, Stocks, C, Patrick, SW. Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010\u20132017. JAMA, J Am Med Assoc 2021;325:146\u201355. https:\/\/doi.org\/10.1001\/jama.2020.24991.","DOI":"10.1001\/jama.2020.24991"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_024","doi-asserted-by":"crossref","unstructured":"Wang, F, Roy, S. Gut homeostasis, microbial dysbiosis, and opioids. Toxicol Pathol 2017;45:150\u20136. https:\/\/doi.org\/10.1177\/0192623316679898.","DOI":"10.1177\/0192623316679898"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_025","doi-asserted-by":"crossref","unstructured":"Wang, J, Barke, RA, Charboneau, R, Roy, S. Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J Immunol 2005;174:426\u201334. https:\/\/doi.org\/10.4049\/jimmunol.174.1.426.","DOI":"10.4049\/jimmunol.174.1.426"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_026","doi-asserted-by":"crossref","unstructured":"Wang, J, Barke, RA, Roy, S. Transcriptional and epigenetic regulation of interleukin-2 gene in activated T cells by morphine. J Biol Chem 2007;282:7164\u201371. https:\/\/doi.org\/10.1074\/jbc.m604367200.","DOI":"10.1074\/jbc.M604367200"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_027","doi-asserted-by":"crossref","unstructured":"Wang, J, Barke, RA, Ma, J, Charboneau, R, Roy, S. Opiate abuse, innate immunity, and bacterial infectious diseases. Arch Immunol Ther Exp (Warsz) 2008;56:299\u2013309. https:\/\/doi.org\/10.1007\/s00005-008-0035-0.","DOI":"10.1007\/s00005-008-0035-0"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_028","doi-asserted-by":"crossref","unstructured":"Jing, M, Wang, J, Wan, J, Charboneau, R, Chang, Y, Barke, RA, et al.. Morphine disrupts interleukin-23 (IL-23)\/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection. Infect Immun 2010;78:830\u20137. https:\/\/doi.org\/10.1128\/iai.00914-09.","DOI":"10.1128\/IAI.00914-09"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_029","doi-asserted-by":"crossref","unstructured":"Meng, J, Banerjee, S, Li, D, Sindberg, GM, Wang, F, Ma, J, et al.. Opioid exacerbation of Gram-positive sepsis, induced by gut microbial modulation, is rescued by IL-17A neutralization. Sci Rep 2015;5:1\u201317. https:\/\/doi.org\/10.1038\/srep10918.","DOI":"10.1038\/srep10918"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_030","doi-asserted-by":"crossref","unstructured":"Roy, S, Ninkovic, J, Banerjee, S, Charboneau, R, Das, S, Dutta, R, et al.. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol 2011;6:442\u201365. https:\/\/doi.org\/10.1007\/s11481-011-9292-5.","DOI":"10.1007\/s11481-011-9292-5"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_031","doi-asserted-by":"crossref","unstructured":"Jalodia, R, Abu, YF, Oppenheimer, MR, Herlihy, B, Meng, J, Chupikova, I, et al.. Opioid use, gut dysbiosis, inflammation, and the nervous system. J Neuroimmune Pharmacol 2022;17:76\u201393. https:\/\/doi.org\/10.1007\/s11481-021-10046-z.","DOI":"10.1007\/s11481-021-10046-z"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_032","doi-asserted-by":"crossref","unstructured":"Callahan, BJ, McMurdie, PJ, Rosen, MJ, Han, AW, Johnson, AJA, Holmes, SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 2016;13:581\u20133. https:\/\/doi.org\/10.1038\/nmeth.3869.","DOI":"10.1038\/nmeth.3869"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_033","doi-asserted-by":"crossref","unstructured":"Wang, Q, Garrity, GM, Tiedje, JM, Cole, JR. Na\u00efve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007;73:5261\u20137. https:\/\/doi.org\/10.1128\/aem.00062-07.","DOI":"10.1128\/AEM.00062-07"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_034","doi-asserted-by":"crossref","unstructured":"McDonald, D, Price, MN, Goodrich, J, Nawrocki, EP, Desantis, TZ, Probst, A, et al.. An improved greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 2012;6:610\u20138. https:\/\/doi.org\/10.1038\/ismej.2011.139.","DOI":"10.1038\/ismej.2011.139"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_035","doi-asserted-by":"crossref","unstructured":"Chong, J, Liu, P, Zhou, G, Xia, J. Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data. Nat Protoc 2020;15:799\u2013821. https:\/\/doi.org\/10.1038\/s41596-019-0264-1.","DOI":"10.1038\/s41596-019-0264-1"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_036","doi-asserted-by":"crossref","unstructured":"Segata, N, Izard, J, Waldron, L, Gevers, D, Miropolsky, L, Garrett, WS, et al.. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12. https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60.","DOI":"10.1186\/gb-2011-12-6-r60"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_037","doi-asserted-by":"crossref","unstructured":"Chen, S, Zhou, Y, Chen, Y, Gu, J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. In: Bioinformatics. Oxford University Press; 2018:i884\u201390 pp.","DOI":"10.1093\/bioinformatics\/bty560"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_038","doi-asserted-by":"crossref","unstructured":"Pertea, M, Kim, D, Pertea, GM, Leek, JT, Salzberg, SL. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat Protoc 2016;11:1650\u201367. https:\/\/doi.org\/10.1038\/nprot.2016.095.","DOI":"10.1038\/nprot.2016.095"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_039","doi-asserted-by":"crossref","unstructured":"Liao, Y, Smyth, GK, Shi, W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 2014;30:923\u201330. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656.","DOI":"10.1093\/bioinformatics\/btt656"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_040","doi-asserted-by":"crossref","unstructured":"Love, MI, Huber, W, Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014;15. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","DOI":"10.1186\/s13059-014-0550-8"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_041","doi-asserted-by":"crossref","unstructured":"Kanehisa, M, Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28. https:\/\/doi.org\/10.1093\/nar\/28.1.27.","DOI":"10.1093\/nar\/28.1.27"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_042","doi-asserted-by":"crossref","unstructured":"Yu, G, Wang, LG, Han, Y, He, QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 2012;16:284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","DOI":"10.1089\/omi.2011.0118"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_043","doi-asserted-by":"crossref","unstructured":"Luo, W, Brouwer, C. Pathview: an R\/bioconductor package for pathway-based data integration and visualization. Bioinformatics 2013;29:1830\u20131. https:\/\/doi.org\/10.1093\/bioinformatics\/btt285.","DOI":"10.1093\/bioinformatics\/btt285"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_044","doi-asserted-by":"crossref","unstructured":"Ko, JY, D\u2019Angelo, DV, Haight, SC, Morrow, B, Cox, S, Salvesen von Essen, B, et al.. Vital signs: prescription opioid pain reliever use during pregnancy \u2013 34 U.S. jurisdictions, 2019. MMWR Morb Mortal Wkly Rep 2020;69:897\u2013903. https:\/\/doi.org\/10.15585\/mmwr.mm6928a1.","DOI":"10.15585\/mmwr.mm6928a1"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_045","doi-asserted-by":"crossref","unstructured":"Patrick, SW, Dudley, J, Martin, PR, Harrell, FE, Warren, MD, Hartmann, KE, et al.. Prescription opioid epidemic and infant outcomes. Pediatrics 2015;135:842\u201350. https:\/\/doi.org\/10.1542\/peds.2014-3299.","DOI":"10.1542\/peds.2014-3299"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_046","doi-asserted-by":"crossref","unstructured":"Feder, KA, Letourneau, EJ, Brook, J. Children in the opioid epidemic: addressing the next generation\u2019s public health crisis. Pediatrics 2019;143:1\u20133. https:\/\/doi.org\/10.1542\/peds.2018-1656.","DOI":"10.1542\/peds.2018-1656"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_047","doi-asserted-by":"crossref","unstructured":"Burton, GJ, Fowden, AL, Thornburg, KL. Placental origins of chronic disease. Physiol Rev 2016;96:1509\u201365. https:\/\/doi.org\/10.1152\/physrev.00029.2015.","DOI":"10.1152\/physrev.00029.2015"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_048","doi-asserted-by":"crossref","unstructured":"Abu, Y, Tao, J, Dutta, R, Yan, Y, Vitari, N, Kolli, U, et al.. Brief hydromorphone exposure during pregnancy sufficient to induce maternal and neonatal microbial dysbiosis. J Neuroimmune Pharmacol 2021:0123456789. https:\/\/doi.org\/10.1007\/s11481-021-10019-2.","DOI":"10.1007\/s11481-021-10019-2"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_049","doi-asserted-by":"crossref","unstructured":"Antoine, D, Singh, PK, Tao, J, Roy, S. Neonatal morphine results in long-lasting alterations to the gut microbiome in adolescence and adulthood in a murine model. Pharmaceutics 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14091879.","DOI":"10.3390\/pharmaceutics14091879"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_050","doi-asserted-by":"crossref","unstructured":"Lyu, Z, Schmidt, RR, Martin, RE, Green, MT, Kinkade, JA, Mao, J, et al.. Long-term effects of developmental exposure to oxycodone on gut microbiota and relationship to adult behaviors. mSystems 2022;7:1\u201314.","DOI":"10.1128\/msystems.00336-22"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_051","doi-asserted-by":"crossref","unstructured":"Grecco, GG, Gao, Y, Gao, H, Liu, Y, Atwood, BK. Prenatal opioid administration induces shared alterations to the maternal and offspring gut microbiome: a preliminary analysis. Drug Alcohol Depend 2021;227:108914. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108914.","DOI":"10.1016\/j.drugalcdep.2021.108914"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_052","doi-asserted-by":"crossref","unstructured":"Prager, I, Liesche, C, van Ooijen, H, Urlaub, D, Verron, Q, Sandstr\u00f6m, N, et al.. NK cells switch from granzyme B to death receptor \u2013 mediated cytotoxicity during serial killing. J Exp Med 2019;216:2113\u201327. https:\/\/doi.org\/10.1084\/jem.20181454.","DOI":"10.1084\/jem.20181454"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_053","doi-asserted-by":"crossref","unstructured":"Law, RHP, Lukoyanova, N, Voskoboinik, I, Caradoc-Davies, TT, Baran, K, Dunstone, MA, et al.. The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature 2010;468:447\u201351. https:\/\/doi.org\/10.1038\/nature09518.","DOI":"10.1038\/nature09518"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_054","doi-asserted-by":"crossref","unstructured":"Grandis, JR, Drenning, SD, Zeng, Q, Watkins, SC, Melhem, MF, Endo, S, et al.. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci 2000;97:4227\u201332. https:\/\/doi.org\/10.1073\/pnas.97.8.4227.","DOI":"10.1073\/pnas.97.8.4227"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_055","doi-asserted-by":"crossref","unstructured":"Hillmer, EJ, Zhang, H, Li, HS, Watowich, SS. STAT3 signaling in immunity. Cytokine Growth Factor Rev 2016;31:1\u201315. https:\/\/doi.org\/10.1016\/j.cytogfr.2016.05.001.","DOI":"10.1016\/j.cytogfr.2016.05.001"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_056","doi-asserted-by":"crossref","unstructured":"Koo, BH, Han, JH, Yeom, YI, Kim, DS. Thrombin-dependent MMP-2 activity is regulated by heparan sulfate. J Biol Chem 2010;285:41270\u20139. https:\/\/doi.org\/10.1074\/jbc.m110.171595.","DOI":"10.1074\/jbc.M110.171595"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_057","doi-asserted-by":"crossref","unstructured":"Sadovsky, E, Chu, T, Barak, O, Sadovsky, Y, Ouyang, Y. The impact of opioids on the transcriptional landscape of human villous trophoblasts. Placenta 2023;143:54\u201361. https:\/\/doi.org\/10.1016\/j.placenta.2023.10.001.","DOI":"10.1016\/j.placenta.2023.10.001"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_058","doi-asserted-by":"crossref","unstructured":"Radhakrishna, U, Nath, SK, Vishweswaraiah, S, Uppala, LV, Forray, A, Muvvala, SB, et al.. Maternal opioid use disorder: placental transcriptome analysis for neonatal opioid withdrawal syndrome. Genomics 2021;113:3610\u20137. https:\/\/doi.org\/10.1016\/j.ygeno.2021.08.001.","DOI":"10.1016\/j.ygeno.2021.08.001"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_059","doi-asserted-by":"crossref","unstructured":"Sousa, A, Besong, OTO, Wachman, EM, Taglauer, ES, Beane, JE, Kefella, Y, et al.. Placental transcriptome analysis in opioid-exposed versus non-opioid exposed pregnancies. Placenta 2025;162:27\u201334. https:\/\/doi.org\/10.1016\/j.placenta.2025.02.012.","DOI":"10.1016\/j.placenta.2025.02.012"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_060","doi-asserted-by":"crossref","unstructured":"Azuine, RE, Ji, Y, Chang, HY, Kim, Y, Ji, H, DiBari, J, et al.. Prenatal risk factors and perinatal and postnatal outcomes associated with maternal opioid exposure in an urban, low-income, multiethnic US population. JAMA Netw Open 2019;2:e196405. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.6405.","DOI":"10.1001\/jamanetworkopen.2019.6405"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_061","doi-asserted-by":"crossref","unstructured":"Malhotra, A, Allison, BJ, Castillo-Melendez, M, Jenkin, G, Polglase, GR, Miller, SL. Neonatal morbidities of fetal growth restriction: pathophysiology and impact. Front Endocrinol (Lausanne) 2019;10. https:\/\/doi.org\/10.3389\/fendo.2019.00055.","DOI":"10.3389\/fendo.2019.00055"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_062","doi-asserted-by":"crossref","unstructured":"Morgan, TK. Placental insufficiency is a leading cause of preterm labor. NeoReviews 2014;15:e518\u201325. https:\/\/doi.org\/10.1542\/neo.15-12-e518.","DOI":"10.1542\/neo.15-12-e518"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_063","doi-asserted-by":"crossref","unstructured":"Green, MT, Martin, RE, Kinkade, JA, Schmidt, RR, Bivens, NJ, Tuteja, G, et al.. Maternal oxycodone treatment causes pathophysiological changes in the mouse placenta. Placenta 2020;100:96\u2013110. https:\/\/doi.org\/10.1016\/j.placenta.2020.08.006.","DOI":"10.1016\/j.placenta.2020.08.006"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_064","doi-asserted-by":"crossref","unstructured":"Ahmed, MS, Cemerikic, B, Mou, S, Agbas, A. Effects of methadone use during pregnancy on human placental opioid receptors. Membr Biochem 1993;10:91\u20138. https:\/\/doi.org\/10.3109\/09687689309150256.","DOI":"10.3109\/09687689309150256"},{"key":"2025123112070693475_j_nipt-2025-0011_ref_065","unstructured":"Mantione, KJ, Angert, RM, Cadet, P, Kream, RM, Stefano, GB. Identification of a \u00b5 opiate receptor signaling mechanism in human placenta. Med Sci Monit 2010;16:BR347\u201352."},{"key":"2025123112070693475_j_nipt-2025-0011_ref_066","doi-asserted-by":"crossref","unstructured":"Rosenfeld, CS. The placenta as a target of opioid drugs. Biol Reprod 2022;106:676\u201386. https:\/\/doi.org\/10.1093\/biolre\/ioac003.","DOI":"10.1093\/biolre\/ioac003"}],"container-title":["NeuroImmune Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2025-0011\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2025-0011\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:07:33Z","timestamp":1767182853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2025-0011\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":66,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,25]]},"published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1515\/nipt-2025-0011"],"URL":"https:\/\/doi.org\/10.1515\/nipt-2025-0011","relation":{},"ISSN":["2750-6665"],"issn-type":[{"type":"electronic","value":"2750-6665"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}